EICHOR
● Recruiting
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
Condition: Castration-Resistant Prostate Cancer (CRPC) · Castration-Resistant Prostate Cancer · Prostate Cancer · Sponsor: Monte Rosa Therapeutics, Inc
About this study
This Phase 2, open-label, multicenter study is conducted in patients with castration-resistant prostate cancer. Patients in this study receive MRT-2359, an investigational oral medicine, in combination with apalutamide, an oral medicine used to treat prostate cancer. The main purpose of the study is to assess whether this treatment combination can lower prostate-specific antigen (PSA) The study will also evaluate the safety and tolerability of the treatment combination and assess additional measures of anti-tumor activity.
This description comes directly from the study's public registry record.
Talk to the study team
Monte Rosa Therapeutics Sponsor · 617-865-4792 · MRT-2359-002StudyTeam@monterosatx.com
Always discuss trial participation with your own doctor first.
Locations (14)
| START Los Angeles | Los Angeles, California, United States | Recruiting |
| Hoag Memorial Hospital Presbyterian | Newport Beach, California, United States | Not Yet Recruiting |
| Rocky Mountain Cancer Center | Colorado Springs, Colorado, United States | Not Yet Recruiting |
| Kansas University Cancer Center | Kansas City, Kansas, United States | Not Yet Recruiting |
| University of Maryland Greenebaum Cancer Center | Baltimore, Maryland, United States | Not Yet Recruiting |
| Henry Ford | Novi, Michigan, United States | Not Yet Recruiting |
| XCancer Omaha | Omaha, Nebraska, United States | Not Yet Recruiting |
| START New Jersey | East Brunswick, New Jersey, United States | Recruiting |
| Levine Cancer Institute | Charlotte, North Carolina, United States | Not Yet Recruiting |
| Lancaster Urology | Lancaster, Pennsylvania, United States | Not Yet Recruiting |
| Sarah Cannon Research Institute | Nashville, Tennessee, United States | Not Yet Recruiting |
| START Mountain Region | West Valley City, Utah, United States | Recruiting |
+ 2 more locations — full list on the registry record.
Sponsor or site team? See the site landscape for this trial — listed sites, countries, and recruiting-density context.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07745361